Introduction to Focus on Fabry Nephropathy: Biomarkers, Progression, and Disease Severity

被引：2
|
作者：
Warnock, David G. [1 ]
Remuzzi, Giuseppe [2 ,3 ]
Brenner, Barry M. [4 ]
Levin, Adeera [5 ]
Wanner, Christoph [6 ]
机构：
[1] Univ Alabama, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[2] Mario Negri Inst Pharmacol Res, Dept Renal Med, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy
[3] Azienda Osped Osped Riuniti Bergamo, Nephrol Unit, Bergamo, Italy
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[6] Univ Wurzburg, Dept Med, Wurzburg, Germany
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 02期
关键词：
D O I：
10.2215/CJN.08191109
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [41] Nephropathy in Fabry disease: Baseline characteristics of 1262 patients in the Fabry Registry
    Eng, Christine
    Ortiz, Alberto
    Oliveira, Joco
    Waldek, Steven
    Warnock, David
    Cianciaruso, Bruno
    Wanner, Christoph
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S20 - S21
  • [42] Blood Pressure, Proteinuria and Nephropathy in Fabry Disease
    Jain, Gaurav
    Warnock, David G.
    NEPHRON CLINICAL PRACTICE, 2011, 118 (01): : C43 - C48
  • [43] Fabry disease and membranous nephropathy: Case report
    Monte Neto, Jose T.
    Rocha Sobral Filho, Daniel Santos
    Chaves, Roosevelt Valente
    Aldeman, Nayze L. S.
    Reis, Marlene Antonia
    Hadad Monte, Semiramis J.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S82 - S83
  • [44] 8th Update on Fabry Disease: Biomarkers, Progression and Treatment Opportunities in 2024 Abstracts
    不详
    NEPHRON, 2024, 148 (SUPPL 1) : 1 - 76
  • [45] Urinary extracellular vesicles and their molecular cargo as possible biomarkers of Fabry nephropathy
    Levstek, Tina
    Mlinsek, Teo
    Holcar, Marija
    Goricar, Katja
    Lenassi, Metka
    Dolzan, Vita
    Vujkovac, Bojan
    Podkrajsek, Katarina Trebusak
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 204 - 204
  • [46] Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy
    Levstek, Tina
    Bahcic, Erazem
    Vujkovac, Bojan
    Vujkovac, Andreja Cokan
    Tesovnik, Tine
    Remec, Ziga Iztok
    Cuk, Vanja
    Podkrajsek, Katarina Trebusak
    CELLS, 2025, 14 (03)
  • [47] A VALIDATED DISEASE SEVERITY SCORING SYSTEM FOR FABRY DISEASE
    Wanner, Christoph
    Giannini, Edward H.
    Mehta, Atul B.
    Hilz, Max J.
    Beck, Michael
    Bichet, Daniel G.
    Brady, Roscoe O.
    West, Michael
    Germain, Dominique P.
    Waldek, Stephen
    Clarke, Joe T. R.
    Mengel, Eugen
    Strotmann, Joerg M.
    Warnock, David G.
    Linhart, Ales
    CLINICAL THERAPEUTICS, 2010, 32 : S108 - S109
  • [48] Eye findings in Fabry disease and correlation with disease severity
    Shankar, Suma P.
    Bradley, Amy
    Gillespie, Scott
    Stelton, Christopher
    Kharod-Dholakia, Bhairavi
    Laney, Dawn
    Yan, Jiong
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S104 - S105
  • [49] A validated disease severity scoring system for Fabry disease
    Waldek, Stephen
    Giannini, Edward
    Mehta, Atul
    Hilz, Max
    Beck, Michael
    Bichet, Daniel
    Brady, Roscoe
    West, Michael
    Germain, Dominique
    Wanner, Christoph
    Clarke, Joe
    Warnock, David
    Linhart, Ales
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S37 - S37
  • [50] A validated disease severity scoring system for Fabry disease
    Giannini, Edward H.
    Mehta, Atul B.
    Hilz, Max J.
    Beck, Michael
    Bichet, Daniel G.
    Brady, Roscoe O.
    West, Michael
    Germain, Dominique P.
    Wanner, Christoph
    Waldek, Stephen
    Clarke, Joe T. R.
    Mengel, Eugen
    Strotmann, Joerg M.
    Warnock, David G.
    Linhart, Ales
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 283 - 290
12345